Metabolic Syndrome Severity Predicts Mortality in Nonalcoholic Fatty Liver Disease
Authors:
- Mohamed I. ElsaidMEMohamed I. Elsaid
- John F.P. BridgesJBJohn F.P. Bridges
- Na LiNLNa Li
- Vinod K. RustgiVRVinod K. Rustgi
Open Access
- 8 April 2022
- journal article
- research article
- Published by Elsevier in Gastro Hep Advances
- Vol. 1 (3) , 445-456
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart StudyDiabetologia, 2017
- Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority PopulationsDigestive Diseases and Sciences, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- Noninvasive fatty liver markers predict liver disease mortality in the U.S. populationHepatology, 2015
- A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?Atherosclerosis, 2013
- Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trialsDiabetologia, 2012
- Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-UpHepatology, 2010
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical ImplicationsHepatology, 2010
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡Hepatology, 2006